The Bridge - for the treamtent of opioid withdrawal symptom
FDA Cleared Percutaneous Neurological Field Stimulator
88% of Patients Successfully Transitioned to Medication Assisted Treatment
88% of Patients Successfully Transitioned to Medication Assisted Treatment
The bridge is a non-surgical and non-pharmacological option for treating the symptoms of opioid withdrawal at the brain. In November of 2017 the FDA cleared the Bridge for the treatment of the symptoms of opioid withdrawal. FDA gave this indication via the DeNovo process which is the most rigorous FDA process for a type II medical device and it is based not only on safety, but efficacy as well.
88% of Patients Successfully Transitioned to Medication Assisted Treatment
88% of Patients Successfully Transitioned to Medication Assisted Treatment
88% of Patients Successfully Transitioned to Medication Assisted Treatment
Results:
- 62.7% Reduction in C.O.W.S. after 30 Minutes
- 84.6% Reduction in C.O.W.S after 1 Hour
- 97.1% Reduction in C.O.W.S after 5 days
- 88.8% Successfule transition to M.A.T. after 5 days